These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15775565)

  • 1. [Drug therapy for osteoporosis associated with rheumatoid arthritis (vitamin D)].
    Tsurukami H; Nakamura T
    Clin Calcium; 2001 May; 11(5):623-7. PubMed ID: 15775565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology, diagnosis and treatment of osteoporosis].
    Tsurukami H
    Clin Calcium; 2003 Jun; 13(6):722-7. PubMed ID: 15775142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis.
    Ji JD; Woo JH; Choi SJ; Lee YH; Song GG
    Med Hypotheses; 2009 Aug; 73(2):201-2. PubMed ID: 19349124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis].
    Nampei A; Hashimoto J
    Clin Calcium; 2006 Nov; 16(11):1866-70. PubMed ID: 17079854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
    Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
    Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A; Saito E; Wakabayashi T; Suzuki Y
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
    Coulson KA; Reed G; Gilliam BE; Kremer JM; Pepmueller PH
    J Clin Rheumatol; 2009 Jun; 15(4):155-60. PubMed ID: 19363452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy for osteoporosis associated with reumatoid arthritis (bisphosphonates)].
    Hosoi T
    Clin Calcium; 2001 May; 11(5):619-22. PubMed ID: 15775564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O; Delle Sedie A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-induced bone loss: can it be prevented?
    Romas E; Gillespie MT
    Rheum Dis Clin North Am; 2006 Nov; 32(4):759-73. PubMed ID: 17288976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis: whom, when and how to treat?].
    Stepán J
    Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high prevalence of inadequate serum vitamin D levels and implications for bone health.
    Reginster JY
    Curr Med Res Opin; 2005 Apr; 21(4):579-86. PubMed ID: 15899107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary osteoporosis. Fractures in patients with rheumatoid arthritis].
    Furuya T; Nanke Y; Kotake S
    Clin Calcium; 2007 Sep; 17(9):1429-34. PubMed ID: 17767035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.